Bio3 Research S.r.l - Product Pipeline Review - 2015

01:13 EDT 15 Apr 2015 | BioPortfolio Reports

Recently added to the BioPortfolio report store, Bio3 Research S.r.l - Product Pipeline Review - 2015 is a new report from Global Markets Direct published on 2015-03-10. This 24-page report is available in PDF from $1500.

Bio3 Research S.r.l - Product Pipeline Review - 2015


Global Markets Direct’s, ‘Bio3 Research S.r.l - Product Pipeline Review - 2015’, provides an overview of the Bio3 Research S.r.l’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Bio3 Research S.r.l’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


- The report provides brief overview of Bio3 Research S.r.l including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Bio3 Research S.r.l’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Bio3 Research S.r.l’s pipeline products

Reasons to buy

- Evaluate Bio3 Research S.r.l’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Bio3 Research S.r.l in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Bio3 Research S.r.l’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Bio3 Research S.r.l and exploit collaboration and partnership opportunities
- Identify emerging…

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Bio3 Research S.r.l Snapshot 4
Bio3 Research S.r.l Overview 4
Key Information 4
Key Facts 4
Bio3 Research S.r.l - Research and Development Overview 5
Key Therapeutic Areas 5
Bio3 Research S.r.l - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
Bio3 Research S.r.l - Pipeline Products Glance 9
Bio3 Research S.r.l - Early Stage Pipeline Products 9
Preclinical Products/Combination Treatment Modalities 9
Discovery Products/Combination Treatment Modalities 10
Bio3 Research S.r.l - Drug Profiles 11
CTR-1 11
Product Description 11
Mechanism of Action 11
R&D Progress 11
CTR-2 12
Product Description 12
Mechanism of Action 12
R&D Progress 12
CTR-3 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
CT-406 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
CTR-4 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
Bio3 Research S.r.l - Pipeline Analysis 17
Bio3 Research S.r.l - Pipeline Products by Target 17
Bio3 Research S.r.l - Pipeline Products by Molecule Type 18
Bio3 Research S.r.l - Pipeline Products by Mechanism of Action 19
Bio3 Research S.r.l - Recent Pipeline Updates 20
Bio3 Research S.r.l - Dormant Projects 21
Bio3 Research S.r.l - Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Appendix 23
Methodology 23
Coverage 23
Secondary Research 23
Primary Research 23
Expert Panel Validation 23
Contact Us 23
Disclaimer 24

For more information open Bio3 Research S.r.l - Product Pipeline Review - 2015.


Original Article: Bio3 Research S.r.l - Product Pipeline Review - 2015


More From BioPortfolio on "Bio3 Research S.r.l - Product Pipeline Review - 2015"

Quick Search


Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...